Rancho Santa Fe Bio
Laura Lewerentz-Juziuk, MSN, is the Chief Operating Officer of the Company. She has over 20 years of experience as a clinical catalyst and entrepreneur bridging business and scientific acumen to corporate, compliance, and commercialization strategies. Currently navigating ataciguat through clinical structures, strengthening and positioning the company for market access. She formerly developed a pre-cell cytology technology currently used at academic institutions and private companies, founded a privatized cleared IRB enabling DOD/DONHRPP research programs, is tri-lingual and has an extensive benchmark to bedside nursing background. Laura attended UCLA, and UCSD, and maintains base access and privileges.
This person is not in any offices
Rancho Santa Fe Bio
Rancho Santa Fe Bio develops cardiovascular drugs to slow the progression of calcification in patients with aortic valve stenosis.